German TAVI device developer, Transcatheter Technologies GmbH, told us a few weeks ago that it was developing a transcatheter mitral valve to sit alongside its Aortic system. They’ve obviously got the hang of this transcatheter thing, now announcing an EndoVascular Aortic Repair (EVAR) device called Tumbao. In case you were wondering, that’s a rhythmic drum beat, picking up the theme from its Tresillo stablemate.
The most common methods of aortic repair are traditional open surgery and EVAR. In the surgical procedure, the wall of the aneurysm is replaced with a synthetic graft. In the EVAR procedure, a stent graft is inserted percutaneously through the femoral artery into the aneurysm. Unlike surgical aortic repair, recovery after EVAR is typically very fast.
The unique feature of the Transcatheter Technologies platform allows for unprecedented precision-controlled expansion and anchoring of self-expanding Nitinol stents for the treatment of complex aortic aneurysm. With this proprietary system a stent can be repositioned—or even retrieved—if needed.
“We are expanding our platform technology to comprise not only Trinity TAVI for the treatment of aortic stenosis and Tresillo TMVI for the treatment of mitral valve insufficiency, but also a unique system, Tumbao, for endovascular aortic repair. Tumbao is designed to make aortic stenting more precise and safer,” said Wolfgang Goetz, M.D., Ph.D., CEO. “This coated endovascular stent allows for extraordinarily precise positioning and anchoring, thus making the treatment of more complex aortic disorders possible.
“Additionally, a short version of Tumbao can seal endoleaks between an existing aortic stent and the native aortic wall (endovascular aortic sealing),” said Dr. Goetz. “An endoleak is a persisting leak into the aneurysm sac, a common complication of EVAR.”
Source: Business Wire